Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2016

Open Access 01-12-2016 | Research article

Absence of an association of human polyomavirus and papillomavirus infection with lung cancer in China: a nested case–control study

Authors: Danny V. Colombara, Lisa E. Manhart, Joseph J. Carter, Stephen E. Hawes, Noel S. Weiss, James P. Hughes, You-Lin Qiao, Philip R. Taylor, Jennifer S. Smith, Denise A. Galloway

Published in: BMC Cancer | Issue 1/2016

Login to get access

Abstract

Background

Studies of human polyomavirus (HPyV) infection and lung cancer are limited and those regarding the association of human papillomavirus (HPV) infection and lung cancer have produced inconsistent results.

Methods

We conducted a nested case–control study to assess the association between incident lung cancer of various histologies and evidence of prior infection with HPyVs and HPVs. We selected serum from 183 cases and 217 frequency matched controls from the Yunnan Tin Miner’s Cohort study, which was designed to identify biomarkers for early detection of lung cancer. Using multiplex liquid bead microarray (LBMA) antibody assays, we tested for antibodies to the VP1 structural protein and small T antigen (ST-Ag) of Merkel cell, KI, and WU HPyVs. We also tested for antibodies against HPV L1 structural proteins (high-risk types 16, 18, 31, 33, 52, and 58 and low-risk types 6 and 11) and E6 and E7 oncoproteins (high risk types 16 and 18). Measures of antibody reactivity were log transformed and analyzed using logistic regression.

Results

We found no association between KIV, WUV, and MCV antibody levels and incident lung cancer (P-corrected for multiple comparisons >0.10 for all trend tests). We also found no association with HPV-16, 18, 31, 33, 52, and 58 seropositivity (P-corrected for multiple comparisons >0.05 for all).

Conclusions

Future studies of infectious etiologies of lung cancer should look beyond HPyVs and HPVs as candidate infectious agents.
Appendix
Available only for authorised users
Literature
1.
Chen W, Zheng R, Zhang S, Zhao P, Zeng H, Zou X, He J. Annual report on status of cancer in China, 2010. Chin J Cancer Res. 2014;26:48–58.PubMedPubMedCentral
2.
3.
She J, Yang P, Hong Q, Bai C. Lung cancer in China: Challenges and interventions. Chest. 2013;143:1117–26.CrossRefPubMed
4.
Lubin JH, Wang ZY, Boice JD, Xu ZY, Blot WJ, De Wang L, Kleinerman RA. Risk of lung cancer and residential radon in China: Pooled results of two studies. Int J Cancer. 2004;109:132–7.CrossRefPubMed
5.
6.
7.
8.
Babakir-Mina M, Ciccozzi M, Lo Presti A, Greco F, Perno CF, Ciotti M. Identification of Merkel cell polyomavirus in the lower respiratory tract of Italian patients. J Med Virol. 2010;82:505–9.CrossRefPubMed
9.
Allander T, Andreasson K, Gupta S, Bjerkner A, Bogdanovic G, Persson MAA, Dalianis T, Ramqvist T, Andersson B. Identification of a third human polyomavirus. J Virol. 2007;81:4130–6.CrossRefPubMedPubMedCentral
10.
Gaynor AM, Nissen MD, Whiley DM, Mackay IM, Lambert SB, Wu G, Brennan DC, Storch G a, Sloots TP, Wang D. Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog. 2007;3:e64.CrossRefPubMedPubMedCentral
11.
Helmbold P, Lahtz C, Herpel E, Schnabel PA, Dammann RH. Frequent hypermethylation of RASSF1A tumour suppressor gene promoter and presence of Merkel cell polyomavirus in small cell lung cancer. Eur J Cancer. 2009;45:2207–11.CrossRefPubMed
12.
Joh J, Jenson a B, Moore GD, Rezazedeh A, Slone SP, Ghim S, Kloecker GH. Human papillomavirus (HPV) and Merkel cell polyomavirus (MCPyV) in non small cell lung cancer. Exp Mol Pathol. 2010;89:222–6.CrossRefPubMed
13.
Gheit T, Muñoz JP, Levican J, González C, Ampuero S, Parra B, Gaggero A, Corvalán AH, Meneses M, Tommasino M, Aguayo F. Merkel cell polyomavirus in non-small cell lung carcinomas from Chile. Exp Mol Pathol. 2012;93:162–6.CrossRefPubMed
14.
Hashida Y, Imajoh M, Nemoto Y, Kamioka M, Taniguchi A, Taguchi T, Kume M, Orihashi K, Daibata M. Detection of Merkel cell polyomavirus with a tumour-specific signature in non-small cell lung cancer. Br J Cancer. 2013;108:629–37.CrossRefPubMedPubMedCentral
15.
Babakir-Mina M, Ciccozzi M, Campitelli L, Aquaro S, Lo Coco A, Perno CF, Ciotti M. Identification of the novel KI Polyomavirus in paranasal and lung tissues. J Med Virol. 2009;81:558–61.CrossRefPubMed
16.
Duncavage EJ, Le B, Wang D, Pfeifer JD. Merkel cell polyomavirus: a specific marker for Merkel cell carcinoma in histologically similar tumors. Am J Surg Pathol. 2009;33:1771–7.CrossRefPubMed
17.
Teramoto S, Kaiho M, Takano Y, Endo R, Kikuta H, Sawa H, Ariga T, Ishiguro N. Detection of KI polyomavirus and WU polyomavirus DNA by real-time polymerase chain reaction in nasopharyngeal swabs and in normal lung and lung adenocarcinoma tissues. Microbiol Immunol. 2011;55:525–30.CrossRefPubMed
18.
Schmitt M, Höfler D, Koleganova N, Pawlita M. Human polyomaviruses and other human viruses in neuroendocrine tumors. Cancer Epidemiol Biomarkers Prev. 2011;20:1558–61.CrossRefPubMed
19.
Tolstov YL, Pastrana DV, Feng H, Becker JC, Jenkins FJ, Moschos S, Chang Y, Buck CB, Moore PS. Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int J Cancer. 2009;125:1250–6.CrossRefPubMedPubMedCentral
20.
Carter JJ, Paulson KG, Wipf GC, Miranda D, Madeleine MM, Johnson LG, Lemos BD, Lee S, Warcola AH, Iyer JG, Nghiem P, Galloway DA. Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J Natl Cancer Inst. 2009;101:1510–22.CrossRefPubMedPubMedCentral
21.
Colombara DV, Manhart LE, Carter JJ, Hawes SE, Weiss NS, Hughes JP, Barnett MJ, Goodman GE, Smith JS, Qiao Y-L, Galloway DA. Prior human polyomavirus and papillomavirus infection and incident lung cancer: a nested case–control study. Cancer Causes Control. 2015;26:1835–44.CrossRefPubMedPubMedCentral
22.
Grulich AE, Jin F, Conway EL, Stein AN, Hocking J. Cancers attributable to human papillomavirus infection. Sex Health. 2010;7:244–52.CrossRefPubMed
23.
Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC. Human papillomavirus and cervical cancer. Lancet. 2013;6736.
24.
Yuan H, Myers S, Wang J, Zhou D, Woo JA, Kallakury B, Ju A, Bazylewicz M, Carter YM, Albanese C, Grant N, Shad A, Dritschilo A, Liu X, Schlegel R. Use of Reprogrammed Cells to Identify Therapy for Respiratory Papillomatosis. N Engl J Med. 2012;367:1220–7.CrossRefPubMedPubMedCentral
25.
DiLorenzo TP, Tamsen A, Abramson AL, Steinberg BM. Human papillomavirus type 6a DNA in the lung carcinoma of a patient with recurrent laryngeal papillomatosis is characterized by a partial duplication. J Gen Virol. 1992;73(Pt 2):423–8.CrossRefPubMed
26.
Klein F, Amin Kotb WFM, Petersen I. Incidence of human papilloma virus in lung cancer. Lung Cancer. 2009;65:13–8.CrossRefPubMed
27.
28.
29.
Vanner EA., Shroyer KR. Comments on “HPV and lung cancer risk: A meta-analysis” [Zhai et al., J. Clin. Virol. (in press)]. J Clin Virol. 2015; 63(November 2014):91.
30.
Qiao YL, Taylor PR, Yao SX, Erozan YS, Luo XC, Barrett MJ, Yan QY, Giffen C a, Huang SQ, Maher MM, Forman MR, Tockman MS. Risk factors and early detection of lung cancer in a cohort of Chinese tin miners. Ann Epidemiol. 1997;7:533–41.CrossRefPubMed
31.
Waterboer T, Sehr P, Michael KM, Franceschi S, Nieland JD, Joos TO, Templin MF, Pawlita M. Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem. 2005;51:1845–53.CrossRefPubMed
32.
Waterboer T, Sehr P, Pawlita M. Suppression of non-specific binding in serological Luminex assays. J Immunol Methods. 2006;309:200–4.CrossRefPubMed
33.
Burnett-Hartman AN, Newcomb PA, Schwartz SM, Bostick RM, Pawlita M, Waterboer T, Potter JD. No association between antibodies to sexually transmitted infections and colorectal hyperplastic polyps in men: Minnesota Cancer Prevention Research Unit Polyp Study. Cancer Epidemiol Biomarkers Prev. 2012;21:1599–601.CrossRefPubMedPubMedCentral
34.
Syrjänen S, Waterboer T, Sarkola M, Michael K, Rintala M, Syrjänen K, Grenman S, Pawlita M. Dynamics of human papillomavirus serology in women followed up for 36 months after pregnancy. J Gen Virol. 2009;90(Pt 6):1515–26.CrossRefPubMed
35.
Michael KM, Waterboer T, Sehr P, Rother A, Reidel U, Boeing H, Bravo IG, Schlehofer J, Gärtner BC, Pawlita M. Seroprevalence of 34 human papillomavirus types in the German general population. PLoS Pathog. 2008;4, e1000091.CrossRefPubMedPubMedCentral
36.
Ernst MD. Permutation Methods: A Basis for Exact Inference. Stat Sci. 2004;19:676–85.CrossRef
37.
Syrjänen K. Detection of human papillomavirus in lung cancer: systematic review and meta-analysis. Anticancer Res. 2012;32:3235–50.PubMed
38.
Anantharaman D, Gheit T, Waterboer T, Halec G, Carreira C, Abedi-Ardekani B, McKay-Chopin S, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, Lissowska J, Mates D, Janout V, Foretova L, Bencko V, Rudnai P, Fabianova E, Tjønneland A, Travis RC, Boeing H, Quirós JR, Johansson M, Krogh V, Bueno-de-Mesquita HB, Kotanidou A, Clavel-Chapelon F, Weiderpass E, Johansson M, Pawlita M, Scelo G, et al. No causal association identified for human papillomavirus infections in lung cancer. Cancer Res. 2014;74:3525–34.CrossRefPubMed
39.
Koshiol J, Rotunno M, Gillison ML, Van Doorn L-J, Chaturvedi AK, Tarantini L, Song H, Quint WGV, Struijk L, Goldstein AM, Hildesheim A, Taylor PR, Wacholder S, Bertazzi PA, Landi MT, Caporaso NE. Assessment of human papillomavirus in lung tumor tissue. J Natl Cancer Inst. 2011;103:501–7.CrossRefPubMedPubMedCentral
40.
Gilbert MTP, Haselkorn T, Bunce M, Sanchez JJ, Lucas SB, Jewell LD, Van Marck E, Worobey M. The isolation of nucleic acids from fixed, paraffin-embedded tissues-which methods are useful when? PLoS One. 2007;2, e537.CrossRefPubMedPubMedCentral
41.
Mogha A, Fautrel A, Mouchet N, Guo N, Corre S, Adamski H, Watier E, Misery L, Galibert M-D. Merkel cell polyomavirus small T antigen mRNA level is increased following in vivo UV-radiation. PLoS One. 2010;5, e11423.CrossRefPubMedPubMedCentral
42.
Bohlmeyer T, Le TN, Shroyer AL, Markham N, Shroyer KR. Detection of human papillomavirus in squamous cell carcinomas of the lung by polymerase chain reaction. Am J Respir Cell Mol Biol. 1998;18:265–9.CrossRefPubMed
43.
44.
Leech SN, Kolar a J, Barrett PD, Sinclair S a, Leonard N. Merkel cell carcinoma can be distinguished from metastatic small cell carcinoma using antibodies to cytokeratin 20 and thyroid transcription factor 1. J Clin Pathol. 2001;54:727–9.CrossRefPubMedPubMedCentral
45.
De Paoli P, Carbone A. Carcinogenic viruses and solid cancers without sufficient evidence of causal association. Int J Cancer. 2013;133:1517–29.CrossRefPubMed
46.
Metadata
Title
Absence of an association of human polyomavirus and papillomavirus infection with lung cancer in China: a nested case–control study
Authors
Danny V. Colombara
Lisa E. Manhart
Joseph J. Carter
Stephen E. Hawes
Noel S. Weiss
James P. Hughes
You-Lin Qiao
Philip R. Taylor
Jennifer S. Smith
Denise A. Galloway
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2016
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-016-2381-3

Other articles of this Issue 1/2016

BMC Cancer 1/2016 Go to the issue

Research article

Interleukin 12 shows a better curative effect on lung cancer than paclitaxel and cisplatin doublet chemotherapy

Study protocol

ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)

Research article

The fibronectin III-1 domain activates a PI3-Kinase/Akt signaling pathway leading to αvβ5 integrin activation and TRAIL resistance in human lung cancer cells

Research article

Prognostic value of HER2 status in bladder transitional cell carcinoma revealed by both IHC and BDISH techniques

Research article

Combined chemoradiation of cisplatin versus carboplatin in cervical carcinoma: a single institution experience from Thailand

Research article

Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studies
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits